ORIGINAL RESEARCH published: 09 March 2016 doi: 10.3389/fendo.2016.00022 MicroRNA 214 Is a Potential Regulator of Thyroid Hormone Levels in the Mouse Heart Following Myocardial Infarction, by Targeting the Thyroid-Hormone-Inactivating Enzyme Deiodinase Type III Rob Janssen1 , Marian J. Zuidwijk1 , Alice Muller1 , Alain van Mil2 , Ellen Dirkx3 , Cees B. M. Oudejans4 , Walter J. Paulus1 and Warner S. Simonides1* 1 Department of Physiology, Institute for Cardiovascular Research, VU University Medical Center, Amsterdam, Netherlands, 2 Department of Cardiology, Division of Heart and Lungs, University Medical Center Utrecht, Utrecht, Netherlands, Edited by: 3 Department of Cardiology, Faculty of Health, Medicine and Life Sciences, CARIM School for Cardiovascular Diseases, Alessandro Antonelli, Maastricht University, Maastricht, Netherlands, 4 Department of Clinical Chemistry, Institute for Cardiovascular Research, VU University of Pisa, Italy University Medical Center, Amsterdam, Netherlands Reviewed by: Anthony Martin Gerdes, New York Institute of Technology- Cardiac thyroid-hormone signaling is a critical determinant of cellular metabolism and College of Osteopathic Medicine, function in health and disease. A local hypothyroid condition within the failing heart in USA rodents has been associated with the re-expression of the fetally expressed thyroid-hor- Pieter De Lange, Seconda Università di Napoli, Italy mone-inactivating enzyme deiodinase type III (Dio3). While this enzyme emerges as a *Correspondence: common denominator in the development of heart failure, the mechanism underlying its Warner S. Simonides regulation remains largely unclear. In the present study, we investigated the involvement
[email protected] of microRNAs (miRNAs) in the regulation of Dio3 mRNA expression in the remodeling Specialty section: left ventricle (LV) of the mouse heart following myocardial infarction (MI).